| Name | Title | Contact Details |
|---|
Info Seputar Kata Kata, Fashion, Otomotif, Kecantikan, Hiburan, Kesehatan, Kuliner, Elektronik, Olahraga, Family, Teknologi, Lifestyle, Wisata dan Lain - Lain Lengkap Dan Update
Palmerhill Group is a Washington, DC-based company in the Business Services sector.
Burcon (TSX: BU) is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is committed to delivering next-generation, best-in-class protein solutions, positioning itself as a key player in the rapidly expanding plant-based market. Supporting the growing trend towards a plant-based diet, Burcon offers sustainable protein ingredients that we believe are better for you and better for the planet. For more information, visit www.burcon.ca.
Mintwave is a New York, NY-based company in the Business Services sector.
Since 2007, Rev.1 Engineering® has been a leading provider of innovative solutions to global medical device companies. With an experienced team of 20+ engineers and technicians boasting an industry average of over 20 years, we specialize in developing novel technologies and delivery systems for complex, interventional therapies that drive exponential value in the marketplace. Recently acquired by ASAHI INTECC, we now operate as a subsidiary under ASAHI Filmecc. Our areas of expertise include: - Structural Heart and Delivery Systems - Interventional Cardiology - Drug/Device/Biologics Combination Products - Neuromodulation Devices - Catheter Navigation, Delivery, and Anchoring Systems - Design for Manufacture & Design Transfer - Rapid Operational Improvements (Profitability of Current Manufacturing Lines) - Remediation (Engineering & Documentation) Throughout our journey, we have successfully developed 140+ devices for over 70 client companies, including startups with limited budgets and tight deadlines. Operating in this challenging environment has honed Rev.1 into an efficient and effective medical device development and innovation company, consistently proving to be 2X Faster than in-house development. Our rapid speed to market translates into a distinct competitive and financial advantage for our clients.